Clinical Trial Update: Epigenetic Modifications of Diabetes Mellitus Type I

View source ↗

Summary

Clinical trial NCT01623388, sponsored by Scripps Translational Science Institute, evaluating epigenetic modifications in Type 1 diabetes mellitus, has been with…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 1 Diabetes Mellitus

Snippet

Sponsor: Scripps Translational Science Institute | Conditions: Type I Diabetes | Status: WITHDRAWN